1. Home
  2. VRAX vs MYSZ Comparison

VRAX vs MYSZ Comparison

Compare VRAX & MYSZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

N/A

Current Price

$0.61

Market Cap

972.3K

Sector

Health Care

ML Signal

N/A

Logo My Size Inc.

MYSZ

My Size Inc.

N/A

Current Price

$0.68

Market Cap

869.6K

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
VRAX
MYSZ
Founded
2013
1999
Country
United Kingdom
Israel
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
972.3K
869.6K
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
VRAX
MYSZ
Price
$0.61
$0.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 537.1K
58.8K
Earning Date
11-20-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 57.40
EPS
★ N/A
N/A
Revenue
N/A
★ $142,000.00
Revenue This Year
N/A
$38.86
Revenue Next Year
N/A
$9.69
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 125.40
52 Week Low
$0.10
$0.37
52 Week High
$13.19
$292.78

Technical Indicators

Market Signals
Indicator
VRAX
MYSZ
Relative Strength Index (RSI) 21.31 22.66
Support Level $0.15 $0.37
Resistance Level $1.57 $2.60
Average True Range (ATR) 0.17 0.07
MACD -0.02 0.09
Stochastic Oscillator 10.47 2.36

Price Performance

Historical Comparison
VRAX
MYSZ

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

About MYSZ My Size Inc.

My Size Inc is a fashion technology company operating an integrated portfolio of businesses designed to address the pressing challenges facing fashion brands and retailers today - size and fit accuracy, excess inventory management, circular economy solutions, and international market distribution. The company, through its subsidaries provide end-to-end support across the fashion value chain; delivers AI-driven size and fit solutions for fashion e-commerce companies. The firm has the following four segments: (i) Fashion e-commerce platform, (ii) SaaS solutions, (iii) resale platform for apparel, and (iv) wholesaling of footwear. The company generates the majority of its revenue from the fashion e-commerce platform segment.

Share on Social Networks: